Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Other financing activities (2016 - 2022)

Ovid Therapeutics filings provide 7 years of Other financing activities readings, the most recent being -$56943.0 for Q4 2022.

  • Quarterly Other financing activities changed N/A to -$56943.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $56943.0 through Sep 2022, up 127.19% year-over-year, with the annual reading at $21314.0 for FY2021, 239.89% up from the prior year.
  • Other financing activities hit -$56943.0 in Q4 2022 for Ovid Therapeutics, down from $56943.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $56943.0 in Q3 2022 and bottomed at -$56943.0 in Q4 2022.
  • Average Other financing activities over 5 years is -$2883.7, with a median of -$395.0 recorded in 2018.
  • The largest annual shift saw Other financing activities plummeted 8636.0% in 2019 before it surged 117.17% in 2020.
  • Ovid Therapeutics' Other financing activities stood at -$250.0 in 2018, then plummeted by 8636.0% to -$21840.0 in 2019, then soared by 117.17% to $3750.0 in 2020, then skyrocketed by 468.37% to $21314.0 in 2021, then crashed by 367.16% to -$56943.0 in 2022.
  • Per Business Quant, the three most recent readings for OVID's Other financing activities are -$56943.0 (Q4 2022), $56943.0 (Q3 2022), and $4305.0 (Q2 2022).